PRE 14A

FORM PRE 14A

Company: Tonix Pharmaceuticals Holding Corp.
Filed: March 20, 2013
Period of Report: March 20, 2013
Accession Number: 0001144204-13-016471

View Document ↗ View on SEC.gov ↗